BLNK vs RPRX · rev $42.5M vs P/E 15, rev $1.30B
Blink Charging Co (BLNK) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Blink Charging Co (BLNK) is a engineering & construction company listed on NASDAQ.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported BLNK revenue for 2026-06-30 was $42.5M. Net income was -$17.6M. BLNK currently screens at market cap $94.0M.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
BLNK currently screens at market cap $94.0M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the BLNK and RPRX stock pages for the full models.
Not investment advice.